# Jeremy M. Shefner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeremy-m-shefner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,300 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 71 |
| i10-index | 189 |
| Last Known Institution | Barrow Neurological Institute |
| OpenAlex ID | https://openalex.org/A5014335916 |
| ORCID iD | https://orcid.org/0000-0001-5067-5602 |
| Works | 321 |

## Researcher papers

- [A proposal for new diagnostic criteria for ALS](https://scholariq.org/papers/a-proposal-for-new-diagnostic-criteria-for-als/)
- [Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/trial-of-sodium-phenylbutyrate-taurursodiol-for-amyotrophic-lateral-sclerosis/)
- [A revision of the El Escorial criteria - 2015](https://scholariq.org/papers/a-revision-of-the-el-escorial-criteria-2015/)
- [A clinical trial of creatine in ALS](https://scholariq.org/papers/a-clinical-trial-of-creatine-in-als/)
- [Nusinersen in later-onset spinal muscular atrophy](https://scholariq.org/papers/nusinersen-in-later-onset-spinal-muscular-atrophy/)
- [Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-ceftriaxone-for-amyotrophic-lateral-sclerosis-a-multi/)
- [Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III](https://scholariq.org/papers/phase-ii-trial-of-coq10-for-als-finds-insufficient-evidence-to-justify-phase-iii/)
- [A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis](https://scholariq.org/papers/a-randomized-placebo-controlled-trial-of-topiramate-in-amyotrophic-lateral/)
- [Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>](https://scholariq.org/papers/long-term-survival-of-participants-in-the-scp-centaur-scp-trial-of-sodium/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Muscle activation and electromyography studies](https://scholariq.org/topics/muscle-activation-and-electromyography-studies/)

## Researcher university

- [Barrow Neurological Institute](https://scholariq.org/institutions/barrow-neurological-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.